Get started
Author

Hamza A. Alshannaq

Observed names: Al-Shannaq, Hamza, H Alshannaq, H. Alshannaq, HAMZA ALSHANNAQ, Hamza Alshannaq, Hamzeh Alshannaq
ORCID: 0000-0003-3952-1113
Observed ORCID: 0000-0003-3952-1113
OpenAlex ID: A5007188753
Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK
2022 · John J. Isitt, Stéphane Roze, et al. · Diabetes Therapy · 41
PDF
Causes of family separation and barriers to reunification: Syrian refugees in Jordan
2020 · Hannah Chandler, Neil Boothby, et al. · Journal of Refugee Studies · 28
Impact of Separation on Refugee Families: Syrian Refugees in Jordan
2018 · McNatt, Zahirah, Boothby, Neil G., et al. · Figshare · 23
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada
2023 · Hamza Alshannaq, John J Isitt, et al. · Journal of Comparative Effectiveness Research · 19
Cost‐utility of real‐time continuous glucose monitoring versus self‐monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark
2023 · Hamza Alshannaq, Greg Cogswell, et al. · Diabetes Obesity and Metabolism · 15
PDF
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France
2024 · Hamza Alshannaq, Richard F Pollock, et al. · Journal of Comparative Effectiveness Research · 13
Real-time continuous glucose monitoring vs. self-monitoring of blood glucose: cost-utility in South Korean type 2 diabetes patients on intensive insulin
2024 · Ji Yoon Kim, Sabrina Ilham, et al. · Journal of Medical Economics · 11
PDF
Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain
2024 · Juan Francisco Merino-Torres, Sabrina Ilham, et al. · ClinicoEconomics and Outcomes Research · 8
Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review
2026 · Grazia Aleppo, Anders L. Carlson, et al. · Diabetes Technology & Therapeutics · 6
The cost-effectiveness of real-time continuous glucose monitoring versus intermittently scanned continuous glucose monitoring in individuals with insulin-treated Type 2 diabetes mellitus in Canada
2025 · Michael Willis, Andreas Nilsson, et al. · Journal of Comparative Effectiveness Research · 4
PDF
1035-P: Cost-Effectiveness of Real-Time CGM vs. Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes from a U.S. Payor Perspective
2024 · HAMZA ALSHANNAQ, GREGORY J. NORMAN, et al. · Diabetes · 3
Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia
2025 · Hamza Alshannaq, David Simmons, et al. · Advances in Therapy · 2
PDF
Cost-Utility of Real-Time Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Sweden
2025 · Johan Jendle, Sabrina Ilham, et al. · Diabetes Therapy · 2
PDF
Cost-Effectiveness Analysis of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in People With Type 2 Diabetes Treated With Non-Intensive Insulin Therapy in South Korea
2025 · Ji Yoon Kim, Sabrina Ilham, et al. · Journal of Diabetes Science and Technology · 2
Real-time continuous glucose monitoring vs self-monitoring of blood glucose in distinct multi-ethnic cohorts of patients living with insulin-treated type 2 diabetes in the United States: A cost-utility analysis from a Medicare perspective
2025 · Hamza Alshannaq, Jessica Matuoka, et al. · Journal of Managed Care & Specialty Pharmacy · 2
141-LB: Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) from a U.S. Payer Perspective in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (PwT2D on MDI)
2023 · HAMZA ALSHANNAQ, GREGORY J. NORMAN, et al. · Diabetes · 2
1036-P: Cost-Effectiveness of Real-Time CGM vs. Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Intensive Insulin Therapy in Australia
2024 · HAMZA ALSHANNAQ, MOIN AHMED, et al. · Diabetes · 1
142-LB: Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (T2D MDI) in Canada
2023 · HAMZA ALSHANNAQ, GREGORY J. NORMAN, et al. · Diabetes · 1
Comparative Analysis of Primary Prostate Cancer Treatment and Subsequent Metastatic Disease
2022 · Mohammed Shahait, Nadine Hamieh, et al. · Frontiers in Urology · 1
Cost‐effectiveness analysis comparing real‐time continuous glucose monitoring with self‐monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan
2026 · Hirotaka Watada, Shiro Tanaka, et al. · Journal of Diabetes Investigation
Cost‐effectiveness analysis of Dexcom ONE + real‐time continuous glucose monitoring versus self‐monitoring of blood glucose in people with type 2 diabetes in Aotearoa New Zealand
2026 · Ryan G. Paul, Jessica Y. Matuoka, et al. · Diabetes Obesity and Metabolism
Author response for "Cost-effectiveness analysis of Dexcom ONE+ Real-time Continuous Glucose Monitoring versus Self-monitoring of Blood Glucose in People with Type 2 Diabetes in Aotearoa New Zealand"
2026 · Ryan G. Paul, Jessica Y. Matuoka, et al. · Publons reviews and discussion
Author response for "Cost-effectiveness analysis of Dexcom ONE+ Real-time Continuous Glucose Monitoring versus Self-monitoring of Blood Glucose in People with Type 2 Diabetes in Aotearoa New Zealand"
2025 · Ryan G. Paul, Jessica Y. Matuoka, et al. · Publons reviews and discussion
EE626 Budget Impact Analysis (BIA) of Adopting Real-Time Continuous Glucose Monitoring (rt-CGM) vs Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients With Type 1 Diabetes on Insulin Therapy (PWT1D) in Italy
2023 · S. Ilham, H. Alshannaq, et al. · Value in Health
PDF
Author response for "Cost‐utility of real‐time continuous glucose monitoring versus self‐monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark"
2023 · Hamza Alshannaq, Greg Cogswell, et al. · Publons reviews and discussion
Works count: 28
Citation count: 184
H-index: 8
I10-index: 7
Year
Topic
Type